Medicare by State. Covered Services Under Medicare Part B. Medicare Part B helps cover preventive services (like medical checkups and screenings) and medically necessary services (like supplies or services you need to treat a medical condition). See the table below for an overview of some of Medicare Part B benefits and services.
Febuxostat (INN; trade names Adenuric in Europe and New Zealand, Uloric in the US, Goturic in Latin America, Feburic in Japan) is a drug that inhibits xanthine oxidase, thus reducing production of uric acid in the body. It is used in the treatment of chronic gout and hyperuricemia. Febuxostat was discovered by scientists at the Japanese pharmaceutical company Teijin in 1998. Teijin partnered the drug with TAP Pharmaceuticals in the US and Ipsen in Europe.
No dose adjustment is necessary when administering Uloric in patients with mild to moderate renal impairment [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)]. The recommended starting dose of Uloric is 40 mg once daily.